Literature DB >> 33384042

Adipokines and the risk of active TB: a nested case-control study.

A Z Soh1, C T Y Tan2, E Mok3, C B E Chee4, J-M Yuan5, A Larbi2, W-P Koh6.   

Abstract

BACKGROUND: Adipokines are emerging mediators of immune response, and may affect susceptibility to active TB.
OBJECTIVE: To examine the associations between adipokines and the risk of active TB.
METHODS: In a case-control study nested within a prospective cohort of middle-aged and older adults in Singapore, 280 incident active TB cases who donated blood for research before diagnosis were matched with 280 controls. Serum levels of adiponectin, resistin, leptin and ghrelin were measured. Multivariable logistic regression models were used to compute the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between adipokines and the risk of active TB.
RESULTS: Higher levels of leptin and resistin were associated with reduced risk of TB in a dose-dependent manner. Compared to those in the lowest quartile of leptin levels, those in the highest quartile had an OR of 0.46 (95%CI 0.26-0.82; P for trend = 0.009). Similarly, compared to those in the lowest quartile of resistin levels, those in the highest quartile had an OR of 0.46 (95%CI 0.24-0.90; P for trend = 0.03). Adiponectin and ghrelin levels were not associated with TB risk.
CONCLUSION: Increased serum levels of leptin and resistin may be associated with reduced susceptibility to active TB infection.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33384042     DOI: 10.5588/ijtld.20.0300

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  The impact of pulmonary tuberculosis on immunological and metabolic features of diabetic patients.

Authors:  Haijun Chen; Li Su; Jinhua Bao; Kun Zhang; Yuze Li; Enuo Mao
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 2.  Evaluating Possible Mechanisms Linking Obesity to COVID-19: a Narrative Review.

Authors:  Maryam Vasheghani; Zahra Hessami; Mahsa Rekabi; Atefeh Abedini; Akram Qanavati
Journal:  Obes Surg       Date:  2022-02-03       Impact factor: 3.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.